Covid-19 has undoubtedly been a driving force behind part of this digital adoption, and it will be crucial to track its long-term impact on patient and physician behavior. The Covid-19 pandemic has proven to be a tipping point in the virtualization of healthcare, which has been underway for some time. Virtual health was heralded as a game changer in the healthcare profession more than a decade ago. However, while technology has enabled virtual health, providers, payers, and consumers have been slower to adopt it than expected. The pandemic has caused a shift in how individuals seek care, with an increase in telehealth sessions opening up additional virtual care possibilities.
Virtual Pharmaceutical Companies (VPC) are distinct from other R&D and Biotech industries in that they are solely made up of experienced teams of managers and consultants who coordinate and monitor external research and development groups and service providers to perform all operational activities on a contractual basis. The emergence of virtual business models in biopharma reflects the industry's shifting landscape. It is no longer possible for a large pharmaceutical company to find and develop its own pipeline entirely in-house.
Title : Resveratrol derivatives a new tool for osteogenic induction in the treatment of peri implantitis
Barbara De Filippis, University “G. d’Annunzio, Italy
Title : Non-coding RNAs in the cardiovascular disorders linked to Chronic Kidney Disease
Laurent Metzinger, University of Picardie Jules Verne, France
Title : Drugs as an environmental problem chromatographic and computational studies of drugs partition between soil and water
Anna Weronika Sobanska, Medical University of Lodz, Poland
Title : miR-29b inhibition in triple negative cells target apoptosis and autophagy related mechanisms
Cornelia Braicu, Iuliu Haţieganu University of Medicine and Pharmacy, Romania
Title : Synthesis and in vitro study of antiproliferative heterocyclic scaffolds
Hitendra M Patel, Sardar Patel University, India
Title : Mucoadhesive microcapsule: A novel approach for controlling & sustained drug delivery!
Subas Chandra Dinda, Teerthanker Mahaveer University, India